skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Case of endophthalmitis following intravitreal injections of bevacizumab

Case report

(2057) Views  (460) Full article downloads

Authors: Shinya Komori, AkirA Sawada, Tsutomu Oguni, et al

Published Date July 2010 Volume 2010:4 Pages 773 - 775
DOI: http://dx.doi.org/10.2147/OPTH.S11379

Shinya Komori1, Akira Sawada1, Tsutomu Oguni1, Kiyofumi Mochizuki1, Kiyofumi Ohkusu2

1Department of Ophthalmology, 2Department of Microbiology, Gifu University Graduate School of Medicine, Gifu, Japan

Purpose: We report a case of infectious endophthalmitis that developed after the third intravitreal injection of bevacizumab. The endophthalmitis was caused by Staphylococcus epidermidis.

Methods: Observational case series.

Results: This was a case of a 77-year-old man who had received three intravitreal injections of bevacizumab and developed infectious endophthalmitis. Polymerase chain reaction of an aqueous humor sample showed that the endophthalmitis was caused by S. epidermidis. The patient received intravitreal ceftazidime and vancomycin, and subconjunctival injection of vancomycin. After the intravitreal injections he was treated with topical levofloxacin and cefmenoxime hydrochloride, and intravenous cefpirome. Subsequently, the ocular inflammation gradually decreased and his visual acuity remained at 30/200.

Conclusions: Our findings indicate that endophthalmitis can develop after intravitreal bevacizumab injections. Polymerase chain reaction is useful for differentiation from sterile endophthalmitis.

Keywords: endophthalmitis, bevacizumab, Staphylococcus, antibiotics





 

Other articles by Dr A Sawada

Case of endogenous endophthalmitis caused by Streptococcus equisimilis